chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd dose was not administered yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 14th July 2021, batch number:BA5GK,expiry date:4th November 2022).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. The reporter consented to follow up.
I woke up the next morning experiencing dizziness, nausea and vomitting causing me to not be able to do any of my normal activities. Every time I moved, I would get sick. I stayed in bed and tried to rest the rest of the day. The next day I woke up feeling better so I didn't call my PCP yet. I worked for 3 days that week and at the end of the 3rd day I started feeling sick and nauseous, and throwing up at work. I messaged my NP and she ordered me nausea medicine (Zofran) and I remained sick for 3 days and then resolved.
Itching of the calves; Left arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching of the calves) and INJECTION SITE PAIN (Left arm was sore) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0011M20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date and Cholesterol (High) since an unknown date.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PRURITUS (Itching of the calves) and INJECTION SITE PAIN (Left arm was sore). On 09-Feb-2021, INJECTION SITE PAIN (Left arm was sore) had resolved. At the time of the report, PRURITUS (Itching of the calves) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant included blood pressure medication and cholesterol medication Treatment included Chigger tropical cream
Right armpit pain on the side of my chest; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 06May2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies.  Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included amfetamine aspartate/ amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) used for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 08Apr2021 at 12:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 20:00, the patient experienced right armpit pain on the side of the chest. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event right armpit pain on the side of the chest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right armpit pain on the side of the chest was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
RN reported a improperly stored VARIVAX administration; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.       On 01-OCT-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX), 1 dosage form, lot number T000341 and expiration date on 05-JAN-2022, for prophylaxis.         The vaccine underwent a temperature excursion between 6 degrees Fahrenheit (°F) to 14°F with an average of 11.8°F for 31 hours. No previous temperature excursions. The call was due to digital data logger.
The patient presents to the Urgent Clinic with redness, swelling, warmth and induration to the right deltoid. She received her first Moderna dose 4/7/21 and notes the right deltoid reaction on 4/15/21. She also reports pain and tenderness to the injection site. Pt was advised to ice as needed and antihistamines as needed for localized hypersensitivity reaction. Patient in agreement with plan of care and will continue to monitor for 4-5 days. She will contact her PCP if symptoms persist or worsen beyond the 4-5 days.
Nurse diluted Pfizer vial with 1.6 ml instead of the required 1.8 ml. A patient was waiting for his injection so after the nurse drew up the first dose from the vial, another nurse labeled the dose and vaccinated the patient. The patient waited 15 minutes then left. As the nurse the was drawing up the 6th dose she realized that she did not have enough to complete the entire dose. She notified her supervisor, the provider, and the patient. No new orders were initiated by provider. Director recieved recommendations from pharmacy to discard/waste doses as they were impropperly reconstituted. Doses were wasted and documented in chart notes. Nurse was re-educated on reconstitution.
Right after vaccine given pt felt lightheaded, like she was going to pass out, this occurs frequently when she gets shots. She did not LOC, she just felt close to that. She laid down, had some water, and within about 5 minutes felt completely fine. She had no other sxs during or after.  Additional post-vaccine screening: patient was observed for a total of 45 minutes, she had no further sxs and was d/c to home with instructions to contact ER or UC if sxs should return, worsen. Ok to receive the second dose of vaccine in one month.
red; Feeling hot; Reaction to thimerasol; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a patient who received Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received the 3rd dose of Hepatitis B vaccine. On an unknown date, unknown after receiving Hepatitis B vaccine, the patient experienced injection site erythema, injection site warmth and reaction to excipient. On an unknown date, the outcome of the injection site erythema, injection site warmth and reaction to excipient were unknown.   It was unknown if the reporter considered the injection site erythema, injection site warmth and reaction to excipient to be related to Hepatitis B vaccine.  Additional details were provided as follows: The patient states she received a hepatitis B vaccine series years and experienced a red, hot site reaction. The patient believed it was related to products that have thimerasol in them.   The patient noted that was what the common denominator was years ago. She stated that with the recent flu vaccine of three weeks ago, she asked for non thimerosal containing products. The reporter did not consent to follow-up. This case has been linked with US2019186993, reported by the same reporter for same patient.
Pt admitted on 8/24/2021: He recommended he come to the ER for admission and for bladder irrigation.  The patient has a history of neurogenic bladder and does self catheterization.  He is fully vaccinated for COVID, but did get diagnosed with COVID, I believe on August 13.  It sounds like he has had symptoms for about 2 weeks and about completely resolved.  It appears that he has finished up his 10 days of dexamethasone.  Pt discharged on 8/26/2021: Patient was admitted to the hospital medicine service and Neurology consulted for his gross hematuria.  Foley catheter placed and was started on continues bladder irrigation.  His hematuria improved and resolved and therefore his CBI was turned off.  Neurology recommends continue antibiotics for 5 more days at discharge and aortic has a prescription for cefdinir and I recommended continuing this for 5 more days.  He will follow up in Neurology Clinic soon for further management of his hematuria.  He did have some anemia which is expected from his hematuria and he has follow-up with PCP early next week have a CBC checked. Overall the patient did well during hospital stay and will be discharged home in stable condition.
Night sweats started around Oct 22. Sore throat with pain on the outside of my throat around Oct 24.  Took Aleve to help with the pain.    Made appointment to see the doctor on 10/27/2022. Labs show hyperthyroidism and anemia.  I was having night sweats and lost a few pounds but I had just started a healthy living diet call Optavia on Oct 17, which I thought had caused those symptoms,
Pain and swollen in and under left armpit from Friday 9/3/21 until today, although pain has lessened. Headache, nausea, and vomiting on Sunday 9/5/21.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Celiac disease (Medical history reported as medical condition as celiac disease).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
This case was retrieved via a search of the scientific literature on 13 November 2012. The following is verbatim from the aforementioned article: "Case Description: A 47-year-old man with no significant past medical history presented to clinic 2 days after awakening with pain (left shoulder, posterior aspect of upper left arm, medial aspect of left forearm), numbness (over left 5th finger & posterior lateral aspect of left arm), and muscle weakness (left arm & left hand). He also described shooting pain down his left arm with any movement of the left shoulder most prominently with arm abduction. He reported similar symptoms of shooting pain with palpation of the anterior aspect of his left shoulder. The patient was without any known trauma or preexisting pathological condition to his neck, shoulder, or arms. The only significant recent event was receiving a flu shot 12 days prior to the start of his symptoms. Setting: Tertiary care hospital. Results or Clinical Course: Physical examination revealed no cervical spinal tenderness. Motor testing revealed weakness in his left biceps, left deltoid, and with external shoulder rotation on the left. Adson's sign was positive on the left. Neural tension stretch testing was positive on the left when specifically stretching the median nerve. The patient was prescribed a prednisone taper and pain medication (ULTRACET). Subsequent MRI was significant for findings consistent with a brachial plexus injury (likely Parsonage-Turner Syndrome) considering the patient's symptoms, history, and physical examination findings." It was not reported that patient was hospitalized. The patient's outcome was not reported. Documents held by sender: None.
(1) Pt with a 3 day hx on arrival to ED 01/05/11 w/ productive cough; malaise and chills. (2) CXR: Cont. w/ ZITHROMAX 500 to cover for Acute Bronchitis. Vaccine Failure.
Shingles; pain went from her armpit to her elbow; numbness through the armpit; had difficulty breathing; Lymph nodes were inflamed on the arm; Body aches; Hreadache; chills; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing) and LYMPHADENOPATHY (Lymph nodes were inflamed on the arm) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing), LYMPHADENOPATHY (Lymph nodes were inflamed on the arm), MYALGIA (Body aches), HEADACHE (Hreadache) and CHILLS (chills). At the time of the report, HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing), LYMPHADENOPATHY (Lymph nodes were inflamed on the arm), MYALGIA (Body aches), HEADACHE (Hreadache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided   Reporter did not allow further contact
Received vaccine elsewhere on 12-22-22. Mother reports rash noted the next day on arms & legs. Itchy, scratching. Child seen at our clinic on 12-27-22. Rash on extremities tense, erythematous papules, generalized distribution, no drainage or tenderness. Talked w/ mom the next week. Rash almost completely gone.
This case was reported by a nurse and described the occurrence of red itchy eyes in a male patient who received hepatitis B vaccine recombinant (Engerix-B).  On 03/30/2004, the patient received the first dose of Engerix-B.  The same day, on 03/30/2004, the patient experienced red itchy eyes.  The patient was seen at a physician's office.  The event worsened.
Fever 102.6 for 30 hours, severe headache, weakness, nausea, diarrhea, arm pain with weakness, dizziness, severe body aches.  Felt better within 72 hours
Fever, sore throat, chills, congestion, cough, nausea, muscle aches, tachycardia. Treatment: Tylenol with no improvement Outcome: referred for COVID testing
Severe joint pain knees ankles hips fingers wrists and shoulder blades. Unable to walk or hold things. Started 3hrs after second shot. Gone by Monday 4/05/2021 when I woke up.
fully vaccinated patient contracted covid from caregiver  symptoms: fever, cough, chills, headache, fatigue
Sudden significant nausea 7 hours after vaccine.  Lasted an hour.  Suddenly went away. Muscle and body aches and headaches, beginning about 5 hours after vaccine, lasting for 60 hours.  Swollen lymph glands in neck and under jaw on both sides, 26 hours after vaccine. Significant fatigue, beginning about 6 hours after vaccine, ongoing at hour 52. LARGE RED HARD BLOTCH on vaccinated arm, one inch+ UNDER the vaccine site (which still has bandage on it), TENDER,  ITCHY, ABOUT 32 HOURS AFTER VACCINE.  ONGOING, although the hardness is decreasing, and the redness isn't as angry at hour 52.
I had a breakthrough case of Covid-19 I had very bad cold like symptoms congestion and fatigue sore arm at injection site I was prescribed PAXLOVID.
first Shingrix/October 4, 2020/need to schedule my second one.; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 4th October 2020) and Covid-19 vaccine moderna (1st dose received on unknown date). Concomitant products included COVID-19 MRNA-1273 VACCINE (COVID-19 VACCINE MODERNA).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The case was reported by the patient himself/herself. The age at vaccination was not applicable for this report.  The patient asked how long she should wait to schedule the 2nd Shingrix shot since she received the 2nd dose of moderna covid -19 vaccine on the day of reporting. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
PT fainted & held in seat by boyfriend after receiving #2/2 Pfizer vaccine at 1613.  PT received vaccine at 1600 to L Deltoid & tolerated shot well.  Boyfriend stated PT had a history of anxiety, but doesn't take medications.  1 ammonia inhalant used to revive PT with success but continued to be very lethargic & stated that her fingers felt numb.  VS taken 1615 O2 Sat 99%, RR 24, BP 100/70, HR 76 EMT called and arrived at 1620.  O2 Sat 99% HR 72,k RR 20 prior to PT leaving with EMT to ambulance.  PT more alert and talking with boyfriend & staff prior to leaving.  Boyfriend, mother and sister present when taken into ambulance for evaluation.  Boyfriend reported that PT had a history of anxiety and fainting and that he carries a bottle of alcohol to sprinkle on nose to revive her.  No fainting reported at 1/2 vaccine.  EMT assessed her in the ambulance & cleared her to leave with family at 1637hrs.
COVID+ 12/20/22.  Vaccination Status - Pfizer x4 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider: MD Admission Date: 12/20/2022 Discharge Date: 12/24/2022 Active Hospital Problems   Diagnosis Date Noted POA ? Pneumonia due to COVID-19 virus 12/20/2022 Yes ? Weakness 12/20/2022 Yes ? Vascular parkinsonism  09/08/2021 Yes ? Elevated blood-pressure reading without diagnosis of hypertension 05/18/2021 Yes ? AF (paroxysmal atrial fibrillation)  02/22/2021 Yes ? Complete heart block     Discharge Disposition:  skilled nursing facility  Active Issues Requiring Follow-up:  COVID-19 pneumonia Acute hypoxic respiratory failure - oxygenation stable on 2 L nasal cannula, wean as able at rehab - continue dexamethasone 6mg daily through 12/30/22 - incentive spirometer - if no improvement would consider trial of low dose oral lasix due to hx of known EF 48%, he is not on this typically Frequent falls Acute left lateral hip pain - continue PT and OT at acute rehab - tylenol, ice, lidocaine patch for left thigh/hip pain DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 90 y.o. male with complex PMH, including prior CVA, HLD, paroxysmal A fib on Eliquis, CHB s/p pacemaker, HLD, and colon cancer who presented 12/20/22 due to weakness, fatigue, and possible fall and/or prolonged time on ground. Patient found to be COVID-19 positive. He was reportedly found down on the ground in his independent living facility and was confused. In the ED, vitals on arrival with T 37.2C, HR 60s, RR low 20s, BP 170s-190s/70s-80s, SpO2 92-94% on room air. Pt appeared dehydrated and was given 1L NS bolus, EKG with paced rhythm, Trp 24->23. CXR with cardiomegaly and retrocardiac opacities. Given use of blood thinners, ordered CT head and C spine, which were negative for any acute intracranial process, fracture or dislocation. Pacemaker was interrogated and did not show any abnormal rhythms. CK notably elevated to 2500 on admission and trended down with fluid resuscitation. Xray of left hip obtained and negative for fracture. PT evaluated recommending acute rehab. PMR evaluated initially recommending SAR but he had improvement in pain and was able to meet criteria for acute rehab. He remained on 2L NC through admission and was started on remdesivir (which he completed 4 days of) and dexamethasone which will be continued on discharge. Patient did have a fall early morning 12/23 landing on his knees.  X-rays without evidence of injury however does demonstrate possible CPPD left knee.  Patient without left knee pain currently so no further workup pursued. CXR repeated day before discharge continuing to show pneumonia. He was discharged to acute rehab in stable condition without new complaints.  Inpt Rehab 12/24/22- 1/4/2023
I started having clay colored stools and irregular bowel movements, diarrhea, constipation, and cramps that did not go away over time. I was later diagnosed with Celiacs disease and I strongly feel this vaccination was the ?stressful ? factor that caused my body to develop an autoimmune disorder.
pt recvd pneumococcal vax in approx JAN92 & on 18FEB92 pt's blood was drawn to test for antibody types 3, 14, 7F & 9; pt tested neg; No further details were provided;
I had a Multiple Sclerosis relapse, my right arm and rib cage became numb. Over a period of a few days both of my feet started going numb and the numbness progressed on both sides up to my rib cage. I had difficulty walking.
Had immunizations on 08/03/2004-Right arm deltoid region has golf-ball sized warm and red area with itching and tenderness.
Information has been received from a physician concerning a 69 year old male with atrial fibrillation and gout who on 01-FEB-2007 at 09:31 was vaccinated SC in the left arm with a first dose of Zostavax (Oka/Merck) (lot # 652947/1212F).  On 27-MAY-2007 the patient developed typical shingles over his left shoulder, neck in C7-8 dermatome.  The patient had no prodome pain and it was a mild case.  No additional information was provided.  Additional information has been requested.
General muscle soreness 2 days after vaccine, then peripheral neuropathy started day 3 after vaccine.    Signs progressed to dizziness, numbness of feet and hands,  prickly sensations over arms and legs.  Unable to resume normal daily functions. Symptoms still present as of today
fainted 8-9 times; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 39-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SYNCOPE (medically significant), outcome "unknown", described as "fainted 8-9 times". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Clinical course: The doctors tried to say its all in her head. She is very upset with them.
I received my 2nd dose of Pfizer on 9-10-21 around 10:15am.  The next morning 9-11-21 at around 9:30 am I was sitting in a chair and passed out.  An ambulance was called, my blood pressure was taken twice and it was about 79-43. I was transported to the hospital and given fluids ,Zofran and an ekg. I began coughing while there. Once I was released the coughing persisted and now  my heart is doing all kinds of funny things. The heart trouble began Sat. 9-11-21.  I am still light headed (things try to go dark) as of Mon. 9-13-21. I have no underlying conditions and have been very healthy with no problems until this second dose.